Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
44.74
-0.29 (-0.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Hinge Health Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Hinge Health stock have an average target of 58.25, with a low estimate of 45 and a high estimate of 70. The average target predicts an increase of 30.20% from the current stock price of 44.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hinge Health stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Buy | 9 | 9 | 10 | 10 | 10 | 10 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $50 → $45 | Buy | Maintains | $50 → $45 | +0.58% | Apr 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $50 → $55 | Buy | Maintains | $50 → $55 | +22.93% | Mar 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $65 → $53 | Strong Buy | Maintains | $65 → $53 | +18.46% | Feb 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $50 | Buy | Maintains | $60 → $50 | +11.76% | Feb 11, 2026 |
| Citizens | Citizens | Buy Reiterates $65 | Buy | Reiterates | $65 | +45.28% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
749.12M
from 587.86M
Increased by 27.43%
Revenue Next Year
888.04M
from 749.12M
Increased by 18.54%
EPS This Year
1.93
from -7.77
EPS Next Year
2.31
from 1.93
Increased by 19.68%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 782.6M | 960.8M | ||||
| Avg | 749.1M | 888.0M | ||||
| Low | 660.9M | 773.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 33.1% | 28.3% | ||||
| Avg | 27.4% | 18.5% | ||||
| Low | 12.4% | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 2.63 | 3.24 | ||||
| Avg | 1.93 | 2.31 | ||||
| Low | 1.00 | 1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | 68.1% | ||||
| Avg | - | 19.7% | ||||
| Low | - | -28.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.